Informazioni generali
  • Categoria della malattia Infezioni e infestazioni , Altro (BASEC)
  • Stato di reclutamento reclutamento completato (BASEC/ICTRP)
  • Luogo dello studio
    Zurigo
    (BASEC)
  • Responsabile dello studio Prof. Dr. med. Ilker Uckay ilker.uckay@balgrist.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.03.2025 ICTRP: N/A
  • Ultimo aggiornamento 27.03.2025 13:40
HumRes58879 | SNCTP000005011 | BASEC2022-00800

Broad-spectrum antibiotic prophylaxis in tumor and infectious diseases in orthopedic surgery - the prospective randomized, microbiologist-blinded, stratified superiority study - BAPTIST study

  • Categoria della malattia Infezioni e infestazioni , Altro (BASEC)
  • Stato di reclutamento reclutamento completato (BASEC/ICTRP)
  • Luogo dello studio
    Zurigo
    (BASEC)
  • Responsabile dello studio Prof. Dr. med. Ilker Uckay ilker.uckay@balgrist.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.03.2025 ICTRP: N/A
  • Ultimo aggiornamento 27.03.2025 13:40

Descrizione riassuntiva dello studio

Perioperative antibiotic prophylaxis in orthopedic surgery is evidence-based. While the duration varies worldwide from one to three doses, the choice of prophylactic agents is undisputed. Worldwide, surgeons use first or second generation cephalosporins (or in some cases vancomycin). However, there are certain clinical situations with a high risk of antibiotic-resistant surgical site infections (SSI), regardless of the duration of prophylaxis administered. These resistant SSIs occur in contaminated wounds or during surgical procedures under current therapeutic antibiotics and are based on a "selection" by the antibiotics used for therapy or prophylaxis.

(BASEC)

Intervento studiato

We will make a random selection of the surgical procedures defined by the inclusion criteria in a prospective alternating scheme (1:1) according to the planned timings in the operating rooms. The anesthetists (or the nurses on the wards) administer the standard prophylaxis (or the therapeutic antibiotics), or additionally the broad-spectrum prophylaxis regimen with a dose of vancomycin and gentamicin. In case of clinical suspicion of infection or massive contamination, the surgeons will take at least three microbiological intraoperative tissue samples. Each surgical procedure counts as one intraoperative event. If a patient is debrided multiple times, they may receive a different prophylaxis regimen for each procedure. After the prophylactic treatment, physicians are free to continue with targeted or empirical therapeutic antibiotic therapy. The antibiotic therapy itself is not an objective of this current study.

(BASEC)

Malattie studiate

Comparison of different antibiotic prophylaxes/therapies in different orthopedic/tumor surgical procedures (e.g., spine, technical orthopedics, infectious diseases...).

(BASEC)

Criteri di partecipazione
1) Surgeries under current or recently completed antibiotic therapy (antibiotic-free period <14 days and for more than 4 days) 2) Surgeries for open fractures; including 2nd and 3rd visits 3) Potentially contaminated wound revision in the operating room 4) Orthopedic tumor surgeries (oncological) with prior radiotherapy and/or bone involvement 5) Spine surgeries with ASA score ≥ 3 points, sacral involvement and/or revision surgeries 6) Known skin colonization with multidrug-resistant Gram-negative bacteria defined by infection control during surgery (BASEC)

Criteri di esclusione
1) Surgery without intraoperative microbiological samples 2) Allergy or severe intolerance to vancomycin and/or gentamicin 3) Anticipated clinical follow-up of less than 6 weeks after inclusion 4) Pregnant or breastfeeding women 5) Known transmission of resistant Gram-negative bacteria only in urine or anal area (BASEC)

Luogo dello studio

Zurigo

(BASEC)

non disponibile

Sponsor

Prof. Dr. med. Ilker Uçkay Head Infectiology Balgrist University Hospital Forchstrasse 340 8008 Zürich

(BASEC)

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

Prof. Dr. med. Ilker Uckay

+41 044 386 73 05

ilker.uckay@balgrist.ch

Universitätsklinik Balgrist

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione etica Zurigo

(BASEC)

Data di approvazione del comitato etico

12.07.2022

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
Broad-spectrum Antibiotic Prophylaxis in Tumour and Infected Orthopaedic Surgery - the prospective-randomized, microbiologist-blinded, stratified, supe-riority Trials - BAPTIST trials (BASEC)

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile